MedPath

Comparative Clinical Study on the Efficacy of Khadiradi Kashay and Dadrudavanal Lepa in Treating Dadru Tinea Corporis

Phase 2/3
Not yet recruiting
Conditions
Other specified local infections of the skin and subcutaneous tissue. Ayurveda Condition: DADRU-KUSHTHAH,
Registration Number
CTRI/2025/05/087225
Lead Sponsor
Shree Saptshrungi Ayurved Mahavidyalay, Kamal nagar, Hirawadi, Panchvati, Nashik
Brief Summary

Primary Objectives-1.To evaluate & compare the efficacy of khadiradi kashay & dadrudavanadi lepa in the management of Dadru based on clinical improvement in signs & symptoms including kandu (itching),Raga(Erythema or Redness),Pidika (Eruption),Utsanna mandala (Elevated circular skin Lesion),No of Pidika & size of lesion.

Secondary Objectives-1.To compare the duration required for significant symptomatic relief & lesion clearance in treatment groups.

2)To study the recurrence of infection within a specific follow up period  after completion of therapy

3)To determine whether a combination therapy (oral +topical)provides superior results compared to either alone drug.

Participants - 90 adults diagnosed with dadru meeting inclusion & exclusion criteria from  shree Saptshrungi Ayurved Mahavidyalay And Hospital Nashik.



Interventions -

Group A-Khadiradi kashay internally for 15 days

Group B-Dadrudavanadi lepa externally (LA) 15 days

Group C-Khadiradi kashay internally and Dadrudavanadi lepa externally (LA)



Treatment duration-15 days

Follow up -  0 ,7 th & 15 th day



Data Analysis- Data will be analysed using appropriate statistical Methods to compare the effectiveness of the intervention on the primary and secondary outcomes.



Ethical Consideration-The  study will be conducted in accordance with Ethical Guidelines & with informed consent from participants.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria
  • 1)Patients with classical sign &symptoms of Dadru I.e.kandu,Pidikotpatti, Raga,Utsanna mandala.
  • 2)Patients of either gender and age group between 18-60 years irrespective of religion, occupation and socio-economic status will be selected.
  • 3)Patients having symptoms of dadru kushta within the time period of 6 months.
Exclusion Criteria
  • 1)Patients of Dadru with any secondary complication.
  • 2)Patients who are suffering from any other type of skin disease like Herpes zoster, eczema.
  • 3)Patients who are suffering from any other known case of systemic Diseases I.e.uncontrolled DM etc.
    1. Pregnant and lactating women 5)Patients taking immunosuppressive medications.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To reduce signs and symptoms of dadru (Tinea corporis)7th day
Secondary Outcome Measures
NameTimeMethod
To reduce signs and symptoms of dadru (Tinea Corporis)To reduce recurrence rate of Dadru (Tinea corporis)

Trial Locations

Locations (1)

Shree Saptshrungi Ayurved Medical College and Hospital

🇮🇳

Nashik, MAHARASHTRA, India

Shree Saptshrungi Ayurved Medical College and Hospital
🇮🇳Nashik, MAHARASHTRA, India
Dr Prajkta Anil Inamdar
Principal investigator
7066692947
prajktainamdar123@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.